Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shikimic acid is a naturally occurring organic compound, specifically a cyclohexene, cyclitol, and cyclohexanecarboxylic acid. It serves as a crucial biochemical metabolite in plants and microorganisms, acting as a key intermediate in the shikimate pathway for the biosynthesis of aromatic amino acids such as phenylalanine, tyrosine, and tryptophan. This metabolic pathway is absent in animals. In the pharmaceutical industry, shikimic acid is a vital base material for the production of the antiviral drug oseltamivir (Tamiflu). Beyond its role as a precursor, shikimic acid itself exhibits a range of biological activities, including anti-inflammatory, antioxidant, anti-acne, anti-dandruff, exfoliating, whitening, hair-growth stimulating, antibacterial, and antiplatelet aggregation properties. These diverse effects have led to its application in cosmetics and as a dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shikimic acid.